Lundbeck
HLUN-B.CO
#2717
Rank
โ‚น557.21 B
Marketcap
โ‚น561.62
Share price
-0.15%
Change (1 day)
25.31%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): โ‚น52.79

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น57.77. an increase over its 2024 EPS that were of โ‚น41.71.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025โ‚น47.7614.5%
2024โ‚น41.7129.29%
2023โ‚น32.2623.09%
2022โ‚น26.2137.26%
2021โ‚น19.10-84.61%
2020โ‚น124.09-24.61%
2019โ‚น164.59-42.06%
2018โ‚น284.0740.7%
2017โ‚น201.91146.26%
2016โ‚น81.99-120.48%
2015-โ‚น400.253231.32%
2014-โ‚น12.01-115.78%
2013โ‚น76.13-23.36%
2012โ‚น99.33-48.01%
2011โ‚น191.08-9.68%
2010โ‚น211.5713.72%
2009โ‚น186.0424.32%
2008โ‚น149.65-6.05%
2007โ‚น159.2881.77%
2006โ‚น87.63-16.76%
2005โ‚น105.27-17.58%
2004โ‚น127.73